5,7-dihydroxytryptamine has been researched along with rasagiline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Finberg, JP; Loboda, Y; Rabey, MJ; Sader-Mazbar, O | 1 |
1 other study(ies) available for 5,7-dihydroxytryptamine and rasagiline
Article | Year |
---|---|
Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation.
Topics: 5,7-Dihydroxytryptamine; Animals; Antiparkinson Agents; Basal Ganglia; Clorgyline; Dopamine; Dopamine Agents; Dopaminergic Neurons; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Indans; Levodopa; Male; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Organic Anion Transporters, Sodium-Independent; Oxidopamine; Rats; Rats, Sprague-Dawley; Serotonergic Neurons | 2013 |